The tissue sealants and tissue adhesive market is anticipated to register a CAGR of 8.4% during the forecast period, up from USD 1,509.6 Million in 2021 to reach a valuation of USD 2,876.9 Million by 2027.
| Report Attributes | Details |
|---|---|
| Estimated Base Year Value (2021) | USD 1,509.8 Million |
| Anticipated Forecast Value (2027) | USD 2,876.9 Million |
| Projected Growth Rate (2022 to 2032) | 8.4% CAGR |
Sales of tissue sealants and tissue adhesives are expected to decline as key companies in the market are employing them to rebuild peripheral nerves.
In addition to this, demand for tissue sealants and tissue adhesive is rising because bone-related disorders are expected to propel the growth of the global tissue glue and bio-adhesive sealants market over the forecast period.
For instance, according to the paper 'New Osteoporotic/Vertebral Compression Fractures', published in 2018 by National Center for Biotechnology Information (NCBI), the USA records 700,000 cases of vertebral compression fractures annually.
Increasing R&D in tissue glue and bio-adhesive sealants is also projected to contribute to the growth of the tissue sealants and tissue adhesive market share.
The report sheds light on the factors improving the sales of tissue sealants and tissue adhesive and, in turn, the opportunities for the market players. However, the tissue sealants and tissue adhesive market also face some challenges, which might limit the tissue sealants and tissue adhesive market share from reaching its potential.
Some of the key tissue sealants and tissue adhesive market trends promoting the demand for tissue sealants and tissue adhesive include being employed by key companies to rebuild peripheral nerves.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The tissue sealing and tissue adhesive market are driven by increasing sales of tissue sealants and tissue adhesive products among surgeons due to their efficacy in preventing bleeding during surgery.
These tissue sealants diminish post-operative bleeding. In addition, these tissue sealants are highly effective, easy to use and less prone to microbial infection after surgery.
Factors such as aging the population and rising surgical procedures result in the increased demand for Tissue sealing and tissue adhesive globally.
The stringent regulatory policies and high cost of the products are major restraints of the sales of tissue sealants and tissue adhesive.
The global tissue sealants and tissue adhesive market is predicted to profit from the rising demand for tissue sealants and tissue adhesive number of operations and amputations.
The growth in the number of arthroplasty surgeries is also likely to help expand the sales of tissue sealants and tissue adhesive.
Depending upon the geographic regions global tissue sealants and adhesives market is segmented into seven key regions-North America, Latin America, Eastern Europe, Western Europe, and the Asia Pacific, excluding Japan, Japan, Middle East and Africa.
North America dominates global sales of tissue sealants and tissue adhesive due to the significant spending power of the population and technological advancement. However, Asia Pacific countries are anticipated to witness lucrative growth in demand for tissue sealants and the tissue adhesive market.
Increasing demand for tissue sealants and tissue adhesive market will be driven by increased investments in healthcare infrastructure and state-of-the-art medical research facilities in the Middle East and Africa during the forecast period, as well as a growing population, improved life expectancy, and increased awareness among both patients and physicians regarding available treatment options.
Government-driven price management and reimbursement limits are becoming more common in the APAC region, notably in China and Japan. At the same time, the South American sector remains undeveloped due to a lack of knowledge and price sensitivity in the sales of tissue sealants and adhesives.
The key players in the global tissue sealants and tissue adhesive market are Baxter International Inc., Johnson & Johnson, Exapharma, Smith & Nephew, C.R Bard and Integra LifeSciences.
The sales of tissue sealants and tissue adhesive is led by Johnson & Johnson (Ethicon, Inc.) (USA). The corporation has a well-known brand and a significant regional presence.
It has a robust and diverse product range for surgical sealants and adhesives, including some of the most well-known names.
The report consists of key players contributing to tissue sealants and tissue adhesive market share. It also consists of organic and inorganic growth strategies adopted by market players to improve their market positions. This exclusive report analyses the competitive landscape and the market share of tissue sealants and tissue adhesive by players to strengthen their market position.
Key participants in the sales of tissue sealants and tissue adhesive are focusing on product development and approval to grow their product range. Polygamic, for example, acquired CE certification for LIQOSEAL, an easy-to-use and novel dural sealant patch, in January 2020.
Sales of tissue and tissue Adhesu Market participants are increasingly adopting inorganic operations. CryoLife, Inc., for example, teamed with Misonix in December 2019 to commercialize CryoLife's NeoPatch product for the treatment of a variety of diseases outside of cardiac and vascular surgery.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 8.4% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Product Type, Application, End user Region, |
| Regions Covered | North America; Latin America; Western Europe; Eastern Europe; Asia Pacific; Japan; Middle East and Africa |
| Key Countries Profiled | USA; Canada; Mexico; Brazil; Germany; Italy; UK; Spain; France; Russia; China; India; ASEAN; Australia & New Zealand; Japan; GCG; South Africa |
| Key Companies Profiled | Baxter International Inc.; Johnson & Johnson; Exapharma; Smith & Nephew; C.R Bard and Integra LifeSciences |
| Customization Scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
The tissue sealants and tissue adhesive market is anticipated to register a CAGR of 8.4% during the forecast period.
Key players holding substantial market share include Baxter International Inc., Johnson & Johnson, Exapharma, Smith & Nephew, C.R Bard, and Integra Life Sciences.
As per the analysis, the tissues sealants and tissue adhesive market share is likely to be USD 2876.9 Million by 2027.
Demand for tissue sealants and tissue adhesive is likely to rise on the back of sales of tissue sealants and tissue adhesive products among surgeons due to its efficacy to prevent bleeding during surgery.
| Market Estimated Size in 2024 | USD 2.4 billion |
|---|---|
| Projected Market Value in 2034 | USD 3.5 billion |
| Value-based CAGR from 2024 to 2034 | 3.9% |
| Market Value (2022) | USD 577.08 Million |
|---|---|
| Market Value (2032) | USD 1036.35 Million |
| Market CAGR (2022 to 2032) | 5% |
Explore Medical Supplies Insights
View Reports
Tissue Sealants and Tissue Adhesive Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
